Profit_Albash (@ProfitAlbash) header
Profit_Albash (@ProfitAlbash) profile picture

Long-Term Investor | Tech • AI • Biotech Sharing research, portfolio lessons & insights. Personal journal. Not financial advice.

Joined May 2021
$IONQ: 336% revenue growth. Shareholder returns face a tougher test. Q3 revenue reached $173.8M, including acquired SkyWater. IonQ also reported a $133.6M adjusted EBITDA loss. investors.ionq.com My takeaway: revenue growth, valuation and dilution need to be assessed together. A growing business still needs to turn demand into repeat customers, stronger margins and value per share. The five images break down the real TradingView chart, major institutional holders, macro drivers and illustrative 2027 scenarios. Save this analysis as a reference for the next earnings report. Follow PROFIT ALBASH for company research with clear assumptions and investor takeaways. Personal journal. Not financial advice. #IONQ #QuantumComputing #Investing
153
21 midterm cycles. 21 positive S&P 500 returns. Since 1942, the November–June period following U.S. midterm elections has delivered an average gain of +16.6%, based on the historical data reviewed. The next window: November 2026 – June 2027. The investor takeaway: Historical patterns are not guarantees, but they provide valuable context for positioning capital. For long-term investors, the opportunity is not simply to anticipate a market rally. It is to identify fundamentally strong, reasonably valued companies, accumulate with discipline, and remain invested as business value grows. Political cycles may influence market sentiment. Earnings, valuations, and business fundamentals ultimately matter more. Use history to prepare. Use fundamentals to select. Use discipline to build wealth. Full historical analysis in the five slides below. #SP500 #StockMarket #LongTermInvesting
22
IBM ($IBM) | The Next Chapter of a Technology Giant IBM is no longer just a legacy technology company. Its transformation is built on enterprise AI, hybrid cloud, recurring software revenue, and strong cash generation. But the bigger long-term opportunity may be quantum computing. IBM is targeting fault-tolerant quantum computing by 2029, potentially opening an entirely new chapter in advanced computing. With established businesses generating cash today and investments in tomorrow's technology, IBM offers an interesting combination of stability and long-term growth potential. The investment thesis is not about chasing hype. It is about understanding where technology is heading before its full commercial potential becomes clear. My six-page research covers IBM's fundamentals, financial performance, valuation, quantum ambitions, risks, and investment outlook. PROFIT ALBASH Independent Investment Research #IBM #QuantumComputing #ArtificialIntelligence #Investing
1
66
NVIDIA ($NVDA) | Market Analysis NVIDIA continues to deliver exceptional growth, with revenue increasing 106% year over year. Yet its stock has fallen more than 30% from its 52-week high. Strong business performance doesn't always mean rising stock prices. I've put together a 5-part analysis covering NVIDIA's financial performance, technical indicators, current market conditions, and long-term growth potential. My perspective is simple: A great company can still be an expensive investment. Price matters as much as potential. Investing with patience, backed by research. #NVDA #NVIDIA #AI #StockMarket #Investing
1
2
36,475
🚨 WALL STREET: HISTORY IS ABOUT TO REPEAT ITSELF? 📈 Since 1942, the S&P 500 has reportedly delivered positive returns in 21 out of 21 post-midterm periods (November–June). 📊 Historical average gain: +16.6% The next window begins in November 2026. Will 2027 extend the streak—or break an 84-year pattern? History is a guide, not a guarantee. #SP500 #StockMarket #Investing #WallStreet #Midterms2026
🤖 Made with AI
40
$CRSP remains one of the most interesting high-risk biotech bets for the next 5 years. Approved gene-editing therapy + strong pipeline in oncology, diabetes and next-gen CRISPR programs. My 5-year view: Base: ~$80 Bull: ~$160 Exceptional: ~$400 = ~10x 10x is not the base case, but if commercialization scales and the pipeline delivers, the upside could be significant. #CRSP #CRISPR #Biotech #GeneEditing #GrowthStocks #10xStocks #Investing #StockMarket #LongTermInvesting
🤖 Made with AI
1
112
$PATH — UiPath could be one of the more interesting AI automation opportunities over the next 5 years. The story is changing. UiPath is no longer just an RPA company. It is trying to become the orchestration layer connecting: • AI agents • Software robots • Employees • Enterprise systems At around a ~$6–7B market cap, the upside could become significant if UiPath successfully captures the agentic AI opportunity. My 5-year scenario: Bear Case: ~$10 Base Case: ~$25 Bull Case: ~$40–60 Exceptional Case: ~$130 A move from ~$13 to ~$130 would represent roughly a 10x return. For that to happen, UiPath would likely need: • ARR growth to accelerate toward 20%+ • Strong adoption of AI agent orchestration • Continued margin expansion • Larger enterprise contracts • Successful competition against Microsoft, Salesforce and ServiceNow • A major valuation re-rating 10x is not my base case. But I believe the asymmetry is interesting enough to keep $PATH on my long-term watchlist. The question is simple: Can UiPath evolve from an automation company into one of the core infrastructure platforms for enterprise AI? If yes, today’s valuation may eventually look very small. #PATH #UiPath #AI #ArtificialIntelligence #AgenticAI #Automation #RPA #TechStocks #GrowthStocks #Stocks #StockMarket #Investing #LongTermInvesting #Multibagger #10xStocks #Software #SaaS #EnterpriseAI
🤖 Made with AI
2
2
214
Is this the next Dot-Com bubble? The S&P 500 monthly chart is still bullish, but the risk/reward is no longer easy. Yes, the warning signs are there: • Valuations are high • Mega-cap concentration is extreme • AI is driving a major growth narrative But this is not a copy-paste of 2000. Today’s leaders are profitable, cash-rich, and much stronger than many Dot-Com names were. My plan: don’t panic, don’t chase. Hold quality, trim overextended winners, and keep cash ready for pullbacks. Personal technical view. Not financial advice. #SP500 #StockMarket #DotComBubble #AIStocks #TechnicalAnalysis #Investing #Trading #Macro #Stocks #MarketCycle
🤖 Made with AI
1
59
$DUOL vs $TTD — Technical chart view. $DUOL looks stronger here with improving momentum and a cleaner trend structure. Key area to hold: $115–120. A break above $130 can open the path toward $140–150. $TTD is still in recovery mode. I’m watching $20–22 as the key confirmation zone. Until then, patience is better than aggressive adding. Quick take: DUOL stronger, TTD needs confirmation. Personal technical view. Not financial advice. #DUOL #TTD #Duolingo #TheTradeDesk #Stocks #Investing #TechnicalAnalysis #StockMarket #GrowthStocks #SwingTrading
🤖 Made with AI
1
164
Patience + conviction = edge. $MRNA and $TWST have both delivered strong unrealized returns from my average prices. $MRNA: +177% — bullish recovery, holding core. $TWST: +230% — strong breakout, holding core and trimming selectively. My strategy is simple: protect gains, respect resistance, and let long-term winners work. Not financial advice. #MRNA #TWST #Biotech #Stocks #Investing #TechnicalAnalysis #StockMarket #Portfolio #LongTermInvesting
🤖 Made with AI
1
1
108